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Abstract
To investigate the necessity and potential application of structural genes for expressing heterogenous genes from
Sindbis virus-derived vector, the DNA-based expression vector pVaXJ was constructed by placing the recombinant
genome of sindbis-like virus XJ-160 under the control of the human cytomegalovirus (CMV) promoter of the
plasmid pVAX1, in which viral structural genes were replaced by a polylinker cassette to allow for insertion of
heterologous genes. The defect helper plasmids pVaE or pVaC were developed by cloning the gene of
glycoprotein E3E26KE1 or capsid protein of XJ-160 virus into pVAX1, respectively. The report gene cassette pVaXJ-
EGFP or pV-Gluc expressing enhanced green fluorescence protein (EGFP) or Gaussia luciferase (G.luc) were
constructed by cloning EGFP or G.luc gene into pVaXJ. EGFP or G.luc was expressed in the BHK-21 cells co-
transfected with report gene cassettes and pVaE at levels that were comparable to those produced by report gene
cassettes, pVaC and pVaE and were much higher than the levels produced by report gene cassette and pVaC,
suggesting that glycoprotein is enough for Sindbis virus-derived DNA vector to express heterogenous genes in
host cells. The method of gene expression from Sindbis virus-based DNA vector only co-transfected with envelop E
gene increase the conveniency and the utility of alphavirus-based vector systems in general.
Findings
T h ec o n c e p tt h a ta l p h a v i r u s e sc a nb ed e v e l o p e da s
expression vectors was first established by Xiong et al.
[1]. Since then, Sindbis virus (SINV), a member of
alphavirus, has been developed as vectors for the expres-
sion of heterologous gene [2-4], gene therapy and vac-
cine application [5-8]. Sind b i sv i r u sg e n o m ei sas i n g l e
strand of positive-sense RNA of approximately 12 kb
which is capped at the 5’ terminus and polyadenylated
at the 3’ terminus [9]. The 5’ two-thirds of this RNA
encode the nonstructural proteins (nsP1 through 4).
The 3’ one-third is initially translated as a polyprotein
(NH2-C-E3-E2-6K-E1-COOH) that is processed co- and
posttranslationally to produce the structural proteins
(SPs) (capsid, El and E2). In infected cells, the virion
structural proteins are translated from a subgenomic
mRNA (26S RNA) and produced by transcription of
genome-length complementary (minus) strand from a
highly active subgenomic promoter. Since the nonstruc-
tural protein genes and the structural protein genes are
expressed from two different mRNAs, they may be
expressed independently of one another [10]. Thus, the
high levels of expression of heterologous products are
achieved when the viral structural genes are replaced by
the heterologous coding sequences. Such recombinant
vectors are self-replicating (replicons) and can be intro-
duced into cells as naked RNA or plasmid DNA.
As a Sindbis-like virus, XJ-160 virus (GenBank No.
AF103728) was isolated from a pooled sample of Ano-
pheles mosquitoes collected in Xinjiang, China, in 1990
[11]. Recombinant plasmid pBR-XJ160 is an infectious
full-length cDNA clone of XJ-160 virus, from which res-
cued virus BR-XJ160 can be obtained by transcription in
vitro and transfection. The BR-XJ160 virus raised in BHK-
21 cells was indistinguishable from the XJ-160 virus in its
biological properties, including its plaque morphology,
growth kinetics and suckling mouse neurovirulence [12].
On basis of pBR-XJ160, the effects of the substitutions of
169 Lys and 173Thr in nonstructural protein 1 (nsP1) as
well as nsP2-726 Pro on the infectivity and pathogenesis
of Sindbis virus have been investigated [13,14]. We have
also confirmed the essential role of E2 glycoprotein, espe-
cially the domain of 145-150 aa, in Sindbis virus infection
through the interaction with cellular heparan sulfate
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any medium, provided the original work is properly cited.[15,16]. In addition, we have developed XJ-160 virus-based
RNA vector system, including replicon vector pBRepXJ, a
defective helper (DH) plasmid (pBR-H) and the packaging
cell lines (PCLs) [17,18].
The conventional approaches producing infectious
Sindbis virus RNA and its derived complementary vec-
tors were restricted primarily to in vitro transcription of
cDNA clones from a bacteriophage RNA polymerase
promoter, followed by transfection into permissive cells.
Compared with this method, alphavirus replication can
also be initiated by transfection of plasmid DNA [4,19].
In this case, full-length 5’-capped RNAs are transcribed
in the nucleus using a polymerase II promoter and
transported to the cytoplasm, the site of primary transla-
tion and RNA amplification. Therefore, there is no need
for in vitro transcription and mRNA capping as required
for the transfection of previously described Sindbis
virus-derived RNA vectors. For the construction of XJ-
160 virus-based DNA vector, the recombinant genome
of XJ-160 virus was placed under the control of the
human cytomegalovirus (CMV) promoter of the plasmid
pVAX1 (Invitrogen, USA), in which viral structural
genes were replaced by the sequence of multiple cloning
site (MCS) to allow for insertion of heterologous genes
(Figure 1). The virus non-structural gene sequence (1-
7562nt), divided into three fragments XJ1 (1-2527nt),
Figure 1 Construction of pVaXJ vector derived from XJ-160 virus.
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into pVAX1 between unique NheI and NotI sites. The
sequence of MCS under the control of subgenomic pro-
moter contains several unique enzyme recognition sites,
including NotI, PvuI, FseI, PacI and AscI.A n dt h eD N A
vector derived from XJ-160 virus in this study was
designated as pVaXJ. In addition, two DH plasmids
were developed by cloning the gene of glycoprotein
E3E26KE1 (8355-11297nt) or capsid protein (7563-
8354nt) of XJ-160 virus into pVax1, respectively.
To perform the qualitative and quantitative identifica-
tion of pVaXJ, the report gene cassettes expressing
either green fluorescence protein (EGFP) or Gaussia
luciferase (G.luc) were constructed. In brief, the EGFP
expression cassette pVaXJ-EGFP was constructed by
inserting EGFP gene from the vector pEGFP-N1 (Invi-
trogen, USA) into the vector pVaXJ by digestion with
NotI and AscI. Similarly, G.luc gene was amplified from
pCMV-GLUC-1 vector (NEB, USA), and was inserted
into pVaXJ with FseI and AscI.The G.luc expression cas-
sette was designated as pV-Gluc. To investigate the
functional activity of pVaXJ, and to determine whether
both DH vectors are necessary to express report genes,
BHK-21 cells were co-transfected with pVaXJ-EGFP
+pVaE+pVaC, pVaXJ-EGFP+pVaE or pVaXJ-EGFP
+pVaC, respectively. And the expressions of EGFP were
observed through scanned by an inverted fluorescence
microscope (400×). As can be seen in Figure 2, the
green fluorescence was observed from all of three
groups of BHK-21 cells at 24 hours post-cotransfection.
In contrast, the control was negative. These results
clearly demonstrated that XJ-160 virus-based DNA vec-
tor (pVaXJ) was able to efficiently express report genes
by co-transfection with pVaE, pVaC or both of them,
respectively. Importantly, the level of specific fluores-
cence from the BHK-21 cells co-transfected with
pVaXJ-EGFP+pVaE was comparable to that produced
by pVaXJ-EGFP+pVaC+pVaE, and obviously higher
than that from the BHK-21 cells co-transfected with
pVaXJ-EGFP and pVaC, suggesting that glycoprotein
plays a more important role than capsid protein in
expressing heterogenous gene from pVaXJ vector.
For further comparing the necessity and potential
application of structural genes, expression of G.luc gene
was detected after BHK-21 cells were co-transfected
with pV-Gluc, pV-Gluc+pVaE+pVaC, pV-Gluc+pVaE or
pV-Gluc+pVaC, respectively. Gluc assay was performed
by Gaussia Luciferase Assay System (Promega) following
the manufacturer’s instructions. As shown in Figure 3,
G.luc gene was efficiently expressed in all groups of
BHK-21 cells except that transfected with pV-Gluc plas-
mid, indicating that either glycoprotein or capsid protein
is important for pVaXJ to express report genes. Interest-
ingly, the activity of G.luc observed from the BHK-21
transfected with pV-Gluc+pVaE was much higher than
that from the BHK-21 cells co-transfected with pV-Gluc
+pVaE+pVaC, whose expression efficiency was similar
to that of the BHK-21 cells transfected with pV-Gluc
+pVaC. As mentioned earlier, the alphavirus particles
are surrounded be a lipid bilayer containing envelop gly-
coprotein heterodimer. And the capsid subunits com-
plex with the genome RNA to form a nucleocapsid
acquiring the lipid envelop with embedded viral glyco-
proteins. In addition, the capsid protein of alphaviruses
may be important factor in the inhibitionof host cell
protein synthesis. Therefore, compared with capsid, gly-
coprotein plays a more important role in packaging
virus particles or virus like particles, and is enough for
Figure 3 Expression of G.luc on BHK-21cells.B H K - 2 1c e l l sw e r e
cotransfected with pV-Gluc, pV-Gluc +pVaE, pV-Gluc +pVaC or pV-
Gluc +pVaE +pVaC, respectively. Gluc assay was performed by
Gaussia Luciferase Assay System (Promega) at the indicated time
postinfection.
Figure 2 Expression of EGFP on BHK-21 cells. BHK-21 cells were
cotransfected with pVaXJ-EGFP+pVaE+pVaC, pVaXJ-EGFP+pVaE,
pVaXJ-EGFP+pVaC, respectively, and the expressions of EGFP were
observed through scanned by an inverted fluorescence microscope
(400×) at 24 hours postinfection. The BHK-21 cells without any
transfection (Mock) were used as control.
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nous genes in host cells.
DNA-based vector derived from alphavirus can be
initiated by transfection of plasmid DNA [4,19]. In this
strategy, full-length 5’-capped RNAs are transcribed in
the nucleus using a polymerase II promoter, and trans-
ported to the cytoplasm. Then autocatalytic amplifica-
tion of the vector, proceeds according to the Sindbis
virus replication cycle and results in expression of the
heterologous gene. Thus, as a double-stranded DNA,
DNA-based vector can be directly transfected into the
host cells dispensing with the process of in vitro tran-
scription and mRNA capping, which is required for the
transfection of previously described Sindbis virus-
derived RNA vectors. In this study, we have constructed
DNA-based vector pVaXJ from XJ-160 virus, which
could efficiently express reporter genes in the trans-
fected cells. The XJ-160 virus-derived DNA vectors
described here increase the utility of alphavirus-based
vector systems in general and also provide a vector with
broad potential applications for genetic immunization.
The SINV-derived replicons lacking viral structural
genes are suicide vectors, incapable of packaging into
infectious particles and causing productive infection. To
obtain viable particles, vector replicon can be packaged
into infectious particles by cotransfection of cultured
cells with a defective helper vector, which provides the
virion structural proteins in trans [20]. Two principal
strategies are being performed for construction of DH
vector: (i) engineering recombinant plasmid that
expresses viral subgenomic RNAs (NH2-C-E3-E2-6K-
E1-COOH) and (ii) developing two DH vectors, one
that expresses the capsid protein and a second that
expresses the viral glycoproteins. High levels of expres-
sion of heterologous genes were achieved by using both
of two methods. However, it is not clear which of the
two SPs or both is necessary for SINV-derived vector to
express heterologous coding sequences. In this investiga-
tion, based on the XJ-160 virus-derived DNA vector, our
findings clearly prove that glycoprotein is enough for
Sindbis virus-derived DNA vector to express heteroge-
nous genes in host cells. The method of gene expression
from Sindbis virus-based DNA vector only co-trans-
fected with envelop E gene increases the conveniency
and the utility of alphavirus-based vector systems in
general.
Acknowledgements
This work was supported by the grants from the National Natural Science
Foundation of China (No. 30970160), the Development Grant of State Key
Laboratory for Infectious Disease Prevention and Control (2011SKLID205), the
Major Science and Technology Project for Infectious Disease (No.
2008ZX10004-001; 2009ZX10004-705).
Authors’ contributions
WZ carried out the molecular genetic studies, participated in the sequence
alignment and drafted the manuscript. LT and JL carried out the
immunoassays. HW, JL and JF participated in the sequence alignment and
performed the statistical analysis. GL conceived of the study, and
participated in its design and coordination. All authors read and approved
the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 14 May 2011 Accepted: 10 July 2011 Published: 10 July 2011
References
1. Xiong C, Levis R, Shen P, Schlesinger S, Rice CM, Huang HV: Sindbis virus:
an efficient, broad host range vector for gene expression in animal cells.
Science 1989, 243:1188-1191.
2. Bredenbeek P, Rice CM: Animal RNA virus expression systems. Semin Virol
1992, 3:297-310.
3. Schlesinger S: Alphaviruses-vectors for the expression of heterologous
genes. Trends Biotechnol 1993, 11:18-22.
4. Frolov I, Hoffman TA, Pragai BM, Dryga SA, Huang HV, Schlesinger S, Rice
and CM: Alphavirus-based expression vectors: strategies and
applications. Proc Natl Acad Sci USA 1996, 93:11371-11377.
5. Hariharan MJ, Driver DA, Townsend K, Brumm D, Polo JM, Belli BA,
Catton DJ, Hsu D, Mittelstaedt D, McCormack JE, Karavodin L, Dubensky TW,
Chang SM Jr, Banks TA: DNA immunization against herpes simplex virus:
enhanced efficacy using a Sindbis virusbased vector. J Virol 1998,
72:950-958.
6. Perri S, Greer CE, Thudium K, Barbara D, Legg H, Liu H, Romero RE,
Tang ZQ, Bin Q, Dubensky TW, Vajdy JM, Otten GR, Polo JM: An alphavirus
replicon particle chimera derived from venezuelan equine encephalitis
and sindbis viruses is a potent gene-based vaccine delivery vector. J
Virol 2003, 77:10394-10403.
7. Pan CH, Valsamakis A, Colella T, Nair N, Adams RJ, Polack FP, Greer CE,
Perri S, Polo JM, Griffin DE: Modulation of disease, T cell responses, and
measles virus clearance in monkeys vaccinated with H-encoding
alphavirus replicon particles. Proc Natl Acad Sci USA 2005, 115811-11588.
8. Lin YL, Kwon T, Polo J, Zhu YF, Coates S, Crawford K, Dong C, Wininger M,
Hall J, Selby M, Coit D, Medina-Selby A, McCoin C, Ng P, Drane D, Chien D,
Han J, Vajdy M, Houghton M: Induction of broad CD4+ and CD8+ T-Cell
responses and cross-neutralizing antibodies against hepatitis C virus by
vaccination with Th1-adjuvanted polypeptides followed by defective
alphaviral particles expressing envelope glycoproteins gpE1 and gpE2
and nonstructural proteins 3, 4, and 5. J Virol 2008, 82:7492-7503.
9. Strauss JH, Strauss EG: Structure and replication of the Alphavirus
genome. In The Togaviridae and Flaviviridae. Edited by: Schlesinger S
Schlesinger MJ. Plenum Press, New York; 1986:35-82.
10. Strauss JH, Strauss EG: The alphaviruses: gene expression, replication, and
evolution. Microbiol Rev 1994, 58:491-562.
11. Liang GD, Li L, Zhou GL, Fu SH, Li QP, Li FS, He HH, Jin Q, He Y, Chen BQ,
Hou YD: Isolation and complete nucleotide sequence of a Chinese
Sindbis-like virus. J Gen Virol 2000, 81:1347-1351.
12. Yang YL, Liang GD, Fu SH, Tang Q, Wang LH: Construction and infection
analysis of the full-length cDNA clone of XJ-160 virus, the first Sindbis
virus isolated in China. Virol Sin 2005, 20:173-180.
13. Zhu WY, Yang YL, Fu SH, Wang LH, Zhai YG, Tang Q, Liang GD:
Substitutions of 169Lys and 173Thr in nonstructural protein 1 influence
the infectivity and pathogenicity of XJ-160 virus. Arch Virol 2009,
154:245-253.
14. Zhu WY, Fu SH, Wang JL, He Y, Tang Q, Liang GD: Effects of the nsP2-726
Pro mutation on infectivity and pathogenesis of Sindbis virus derived
from a full-length infectious cDNA clone. Virus Res 2009, 14:204-207.
15. Zhu W, Wang L, Yang Y, Jia J, Fu S, He Y, Li JP, Liang G: Interaction of E2
glycoprotein with heparan sulfate is crucial for cellular infection of
sindbis virus. PLoS ONE 2010, 5(3):e9656.
16. Zhu WY, Fu SH, Li JP, He Y, Liang GD: Amino acid substitutions in the E2
glycoprotein of Sindbis-like virus XJ-160 confer the ability to undergo
heparan sulfate-dependent infection of mouse embryonic fibroblasts.
Virol J 2010, 7:225.
Zhu et al. Virology Journal 2011, 8:344
http://www.virologyj.com/content/8/1/344
Page 4 of 517. Yang YL, Liang GD, Fu SH, Liang GD: The construction of replicon of XJ-
160 virus. Virol Sin 2003, 18:221-226.
18. Zhu WY, Liang GD: Selection and characterization of packaging cell lines
for XJ-160 Virus. Intervirology 2009, 52:100-109.
19. Dubensky TW, Driver DA Jr, Polo JM, Belli BA, Latham EM, Ibanez CE,
Chada S, Brumm D, Banks TA, Mento SJ, Jolly DJ, Chang SMW: Sindbis
virus DNA-based expression vectors: utility for in vitro and in vivo gene
transfer. J Virol 1996, 70:508-519.
20. Bredenbeek PJ, Frolov I, Rice CM, Schlesinger S: Sindbis virus expression
vectors: packaging of RNA replicons by using defective helper RNAs. J
Virol 1993, 67:6439-6446.
doi:10.1186/1743-422X-8-344
Cite this article as: Zhu et al.: Glycoprotein is enough for sindbis virus-
derived DNA vector to express heterogenous genes. Virology Journal
2011 8:344.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Zhu et al. Virology Journal 2011, 8:344
http://www.virologyj.com/content/8/1/344
Page 5 of 5